(4-((2-Methoxyphenyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

L-Azetidine-2-carboxylic acid, 98.0%, 25g

2-(2,4-Dinitrobenzyl)pyridine>98.0%(HPLC)5g

1,2-Dibromo-4-(methylsulfonyl)benzene, 95.0%, 25g

5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione hydrochloride, 97.0%, 1g

4,4'-Bis(bromomethyl)-2,2'-bipyridine, 95.0%, 1g

3-chloro-4-fluoro-4'-thiomorpholinomethyl benzophenone, 97.0%, 1g

2-(Chloromethyl)-1-methylpiperidine hydrochloride, 97.0%, 25g

2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropanoic acid, 95.0%, 5g

ethyl 1H-1,2,4-triazole-5-carboxylate, 95.0%, 10g

3-Bromo-5-(2-fluoropropan-2-yl)pyridine, 98%, 1g

1,6-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene>97.0%(T)(qNMR)1g

Solución de hipoclorito de sodio, 5-10% Cl, tecn., 1 l, envase de plástico.